Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Filings indexed 2,743 across all filing types
Latest filing 2024-02-06 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Newspaper Advertisement- Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023.
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Tata Chemicals Limited regarding the approval and publication of their unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2023. It includes extensive financial data such as revenue, profit before and after tax, earnings per share, and other comprehensive income figures. The document references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures in India. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year (quarter and nine months) confirms this is an Interim / Quarterly Report. The document is not merely an announcement of a report or a certification but contains detailed financial results and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2024
2024-02-06 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Tata Chemicals Limited dated February 6, 2024, regarding the approval and publication of unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2023. It includes extensive financial data such as revenue, profit before and after tax, earnings per share, and other comprehensive income for the specified periods. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs quarterly financial results disclosures in India. The document is not merely an announcement that a report is available but contains substantive financial data and analysis for the quarter and nine months, fulfilling the criteria for an Interim / Quarterly Report. It is not a full annual report (10-K), nor is it a brief earnings release (ER) since it provides detailed financial statements. It is not a certification or attestation letter, so it does not fall under Regulatory Filings (RNS). Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2024
2024-02-06 English
Please find the link to the audio recording of the Analysts/Investors call on the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges providing a link to the audio recording of an analysts/investors call related to the financial results for the third quarter and nine months ended December 31, 2023. It mentions the results were approved by the Board on the same day. The document does not contain the transcript itself, financial data, or detailed analysis, but only a link to the audio recording. This fits the definition of a Call Transcript (CT) document, as it pertains to the earnings call. However, since the actual transcript is not included and only the audio recording link is provided, it is more appropriate to classify this as a Regulatory Filing (RNS) because it is an announcement of the call recording rather than the transcript or report itself. The document length is short (1344 characters), supporting that it is an announcement rather than a full report or transcript.
2024-02-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges providing a link to the audio recording of an analysts/investors call regarding the financial results for the third quarter and nine months ended December 31, 2023. It mentions the results were approved by the Board on the same day. The document does not contain the transcript itself, only a link to the audio recording. This fits the definition of a Call Transcript (CT) as it relates to a conference call about financial results, but since the actual transcript text is not included and only the audio link is provided, it is more appropriate to classify this as a Regulatory Filing (RNS) because it is an announcement/notification about the call recording rather than the transcript or report itself. The document length is short (1344 characters), supporting that it is an announcement rather than a full transcript or report.
2024-02-05 English
Submission of Analyst / Investors Presentation for the Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023
Investor Presentation Classification · 95% confidence The document is a detailed presentation submitted to stock exchanges and investors, containing extensive financial data including revenue, EBITDA, profit before tax, profit after tax, and segment-wise performance for the quarter and nine months ended December 31, 2023. It references unaudited consolidated and audited standalone financial results and includes detailed financial snapshots and sales volumes. The document is titled as an Analysts/Investors Presentation and is explicitly described as such in the submission letter. It is not a brief announcement or a certification, but a comprehensive presentation of financial results and business performance intended for investors and analysts. Therefore, the document fits the category of an Investor Presentation (IP).
2024-02-05 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed presentation addressed to stock exchanges and investors, dated February 5, 2024, concerning the unaudited consolidated and audited standalone financial results for the third quarter and nine months ended December 31, 2023. It includes extensive financial highlights, performance metrics, profit and loss statements, and sales volumes. The document explicitly states it is a presentation to analysts and investors, and it is submitted in compliance with SEBI regulations. The content is typical of an Investor Presentation, focusing on financials, strategy, and market position, rather than a formal earnings release or full interim report. The length (15,000 characters) and detailed financial data support this classification. Therefore, the filing type is Investor Presentation (IP).
2024-02-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.